CSPC Pharmaceutical Group Ltd HKEX:1093:

  • SYS6043 GRANTED BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR PLATINUM-RESISTANT OVARIAN CANCER

  • GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA